J-Pharma Co (TSE:520A) Notes Receivable: 円0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:520A J-Pharma Co Ltd TSE:520A
9 GF Score
Price 円290.00
View Full Analysis

What is J-Pharma Co Notes Receivable?

J-Pharma Co TSE:520A -2.36% 9 Notes Receivable is 円0.00 Mil as of Dec. 2025. GuruFocus rates TSE:520A with a GF Score™ of 9/100.

J-Pharma Co's Notes Receivable for the quarter that ended in Dec. 2025 was 円0.00 Mil.

J-Pharma Co Notes Receivable Historical Data

* Premium members only.

The historical data trend for J-Pharma Co's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

J-Pharma Co Notes Receivable Chart

J-Pharma Co Annual Data
Trend Mar24 Mar25
Notes Receivable
0.00 0.00

J-Pharma Co Quarterly Data
Mar24 Mar25 Dec25
Notes Receivable 0.00 0.00 0.00
TSE:520A
9GF Score
J-Pharma Co Ltd TSE:520A
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

J-Pharma Co Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of 円0.00 Mil mean?
J-Pharma Co (TSE:520A) has a Notes Receivable of 円0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on J-Pharma Co and its competitors.
Is J-Pharma Co's Notes Receivable too high?
J-Pharma Co's current Notes Receivable is 円0.00 Mil. Overall, J-Pharma Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does J-Pharma Co's Notes Receivable compare to VRTX and REGN?
J-Pharma Co's Notes Receivable of 円0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on J-Pharma Co and its competitors. J-Pharma Co's current Notes Receivable is 円0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is J-Pharma Co stock overvalued right now?
J-Pharma Co (TSE:520A) has a current Notes Receivable of 円0.00 Mil. The current Notes Receivable is 円0.00 Mil. J-Pharma Co's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For J-Pharma Co (TSE:520A), the current Notes Receivable is 円0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

J-Pharma Co Business Description

Address 1-10-11, HamamatsuCho, 8th floor, Minato-Ku, Tokyo, JPN, 105-0013
J-Pharma Co Ltd is engaged in the Drug discovery and development targeting SLC transporters. It is focused on a single segment of the drug discovery business, focusing on R&D and clinical development. The company's two compounds in clinical development are Nanbran Latte (JPH203) and JPH034.
9GF Score

Get the complete analysis for TSE:520A

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円290.00
Price